ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

9 links0 made here, not in the record6 judgments1 judge (the rules as one: Rule based)7 record changes seen
Rule basedRecord updated on ClinicalTrials.gov
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03223610Venetoclax, Ibrutinib,Prednisone, Obinutuzumab,and Revlimid (ViPOR) inRelapsed/Refractory B-cellLymphomaNational Cancer Institute (NCIPhase 1/Phase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 28 · ClinicalTrials.gov record · Version of 2026-09-28Oct 13 · ClinicalTrials.gov record · Version of 2026-10-13Oct 16 · ClinicalTrials.gov record · Version of 2026-10-16Oct 29 · ClinicalTrials.gov record · Version of 2026-10-29Nov 5 · ClinicalTrials.gov record · Version of 2026-11-05Nov 9 · ClinicalTrials.gov record · Version of 2026-11-09Nov 12 · ClinicalTrials.gov record · Version of 2026-11-12Version of 2026-11-12CONDITIONSLymphomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Lymphoma, Non-HodgkinThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionLymphoma, Large B-Cell, Dif…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.Burkitt LymphomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSVenetoclaxIntervention entry›As of now · Rule based · TestedTestedIbrutinibIntervention entry›As of now · Rule based · TestedTestedPrednisoneIntervention entry›As of now · Rule based · TestedTestedObinutuzumabIntervention entry›As of now · Rule based · TestedTestedLenalidomideEntry “Revlimid (lenalidomide)”, read…›As of now · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Lymphoma

From the registry record0 judgments on this link
RegistryLymphoma, as filedthe registry files the study under it
=as filed
No judgmentUnchangedshown as the registry files it

All judgments on this study

WhenLinkJudgeDecisionState
Sep 28The record itselfClinicalTrials.gov recordVersion of 2026-09-28Record change
Oct 13The record itselfClinicalTrials.gov recordVersion of 2026-10-13Record change
Oct 16The record itselfClinicalTrials.gov recordVersion of 2026-10-16Record change
Oct 29The record itselfClinicalTrials.gov recordVersion of 2026-10-29Record change
Nov 5The record itselfClinicalTrials.gov recordVersion of 2026-11-05Record change
Nov 9The record itselfClinicalTrials.gov recordVersion of 2026-11-09Record change
Nov 12The record itselfClinicalTrials.gov recordVersion of 2026-11-12Record change
As of nowLymphoma, Non-HodgkinRule based · main-condition ruleMain conditionCurrent
As of nowVenetoclaxRule based · role ruleTestedCurrent
As of nowIbrutinibRule based · role ruleTestedCurrent
As of nowPrednisoneRule based · role ruleTestedCurrent
As of nowObinutuzumabRule based · role ruleTestedCurrent
As of nowLenalidomideRule based · role ruleTestedCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.